COO
The Cooper Companies, Inc.81.04
-0.49-0.6%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
16.11BP/E (TTM)
43.34Basic EPS (TTM)
1.87Dividend Yield
0%Recent Filings
8-K
10-K
8-K
10-Q
Q3 FY2025 results
Cooper Companies posted solid Q3 FY2025 results, with net sales climbing 6% year-over-year to $1.06B, fueled by 6% growth in CooperVision's toric and multifocal lenses alongside 4% gains in CooperSurgical's fertility and office segments, though Europe drove 14% regional expansion. Operating income dipped 9% to $175.7M amid inventory write-offs from a product line exit in CooperSurgical, yet gross margins held near 65% while diluted EPS edged to $0.49 from $0.52, reconciled against 200M shares with minor anti-dilution from excluded options. Cash from operations surged 24% year-to-date to $548.2M, yielding $283.8M free cash flow after $264.4M capex (derived), bolstering $124.9M cash reserves against $2.48B total debt, including a $1.5B term loan at 5.30% maturing 2026 and $1.37B revolver availability through 2029. Acquisitions like obp Surgical in August 2024 for $100M cash added $50.6M goodwill and $45.6M developed technology, enhancing surgical tools. Non-GAAP metrics not disclosed in the 10-Q. Acquisitions integrate synergies, but regulatory hurdles in fertility markets loom large.
8-K
Q3 revenue up 6%, EPS guidance raised
The Cooper Companies reported Q3 fiscal 2025 revenue of $1,060.3 million, up 6% year-over-year, with CooperVision at $718.4 million (up 6%) and CooperSurgical at $341.9 million (up 4%), yet revenues fell short of expectations due to a product line exit at CooperSurgical. Non-GAAP diluted EPS rose 15% to $1.10, bolstered by efficiency gains and lower interest expense, while free cash flow hit $164.6 million. The company raised full-year non-GAAP EPS guidance to $4.08-$4.12, anticipating Q4 revenue improvement from MyDay lenses. Strong margins persist amid integration costs.
IPO
Website
Employees
Sector
Industry
ALC
Alcon Inc.
79.02-0.17
BLCO
Bausch + Lomb Corporation
16.98-0.11
HOLX
Hologic, Inc.
75.02-0.17
ISRG
Intuitive Surgical, Inc.
554.58-4.94
OMI
Owens & Minor, Inc.
3.10+0.09
POCI
Precision Optics Corporation, I
4.20-0.07
RXST
RxSight, Inc.
12.76+0.24
SGHT
Sight Sciences, Inc.
8.39+0.08
STAA
STAAR Surgical Company
24.80+1.24
WRBY
Warby Parker Inc.
26.65-0.19